Healthcare provider profile · identity verified

John P Barsanti, MD

Family Practice · SAINT PAUL, MN · NPI 1144237801

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	635	181
Lisinopril	Lisinopril	524	129
Amlodipine Besylate	Amlodipine Besylate	402	108
Omeprazole	Omeprazole	343	92
Metoprolol Succinate	Metoprolol Succinate	320	90
Gabapentin	Gabapentin	319	79
Simvastatin	Simvastatin	315	84
Metformin Hcl	Metformin Hcl	228	60
Losartan Potassium	Losartan Potassium	218	65
Levothyroxine Sodium	Levothyroxine Sodium	209	50
Albuterol Sulfate Hfa	Albuterol Sulfate	195	59
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	195	25
Metformin Hcl Er	Metformin Hcl	195	52
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	189	18
Tamsulosin Hcl	Tamsulosin Hcl	180	53
Rosuvastatin Calcium	Rosuvastatin Calcium	168	46
Alendronate Sodium	Alendronate Sodium	165	47
Furosemide	Furosemide	163	46
Escitalopram Oxalate	Escitalopram Oxalate	160	35
Hydrochlorothiazide	Hydrochlorothiazide	156	45
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	142	35
Oxycodone Hcl	Oxycodone Hcl	136	26
Trazodone Hcl	Trazodone Hcl	132	36
Allopurinol	Allopurinol	127	31
Metoprolol Tartrate	Metoprolol Tartrate	127	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	119	27
Eliquis	Apixaban	112	26
Zolpidem Tartrate	Zolpidem Tartrate	112	22
Atenolol	Atenolol	107	29
Prednisone	Prednisone	100	50
Warfarin Sodium	Warfarin Sodium	98	22
Famotidine	Famotidine	96	27
Sertraline Hcl	Sertraline Hcl	94	23
Irbesartan	Irbesartan	84	20
Duloxetine Hcl	Duloxetine Hcl	83	17
Xarelto	Rivaroxaban	83	14
Alprazolam	Alprazolam	82	19
Jardiance	Empagliflozin	79	16
Mirtazapine	Mirtazapine	79	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	77	22
Bupropion Xl	Bupropion Hcl	76	13
Ozempic	Semaglutide	75	17
Potassium Chloride	Potassium Chloride	75	19
Lorazepam	Lorazepam	72	17
Pregabalin	Pregabalin	71	14
Quetiapine Fumarate	Quetiapine Fumarate	69	11
Tizanidine Hcl	Tizanidine Hcl	69	14
Glipizide Er	Glipizide	68	20
Fluticasone Propionate	Fluticasone Propionate	66	22
Spironolactone	Spironolactone	66	18
Ventolin Hfa	Albuterol Sulfate	66	15
Donepezil Hcl	Donepezil Hcl	64	11
Valsartan	Valsartan	64	13
Citalopram Hbr	Citalopram Hydrobromide	63	14
Glimepiride	Glimepiride	61	17
Triamcinolone Acetonide	Triamcinolone Acetonide	60	30
Meloxicam	Meloxicam	59	18
Oxybutynin Chloride Er	Oxybutynin Chloride	59	15
Clopidogrel	Clopidogrel Bisulfate	56	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	56	suppressed
Clonazepam	Clonazepam	54	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	53	18
Pravastatin Sodium	Pravastatin Sodium	52	11
Fluoxetine Hcl	Fluoxetine Hcl	50	17
Rybelsus	Semaglutide	50	12
Propranolol Hcl Er	Propranolol Hcl	48	suppressed
Baclofen	Baclofen	47	suppressed
Carvedilol	Carvedilol	45	13
Fenofibrate	Fenofibrate Nanocrystallized	45	suppressed
Tramadol Hcl	Tramadol Hcl	45	13
Cephalexin	Cephalexin	43	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Finasteride	Finasteride	42	12
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	41	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	27
Amitriptyline Hcl	Amitriptyline Hcl	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	39	23
Hydroxyzine Hcl	Hydroxyzine Hcl	38	15
Wixela Inhub	Fluticasone Propion/Salmeterol	38	suppressed
Novolog Flexpen	Insulin Aspart	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Glipizide	Glipizide	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	30	suppressed
Azithromycin	Azithromycin	30	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Sucralfate	Sucralfate	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Naproxen	Naproxen	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Amoxicillin	Amoxicillin	27	22
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Fluconazole	Fluconazole	25	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Nitroglycerin	Nitroglycerin	22	18
Gemfibrozil	Gemfibrozil	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Buspirone Hcl	Buspirone Hcl	20	suppressed
Carbamazepine Er	Carbamazepine	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	15
Valacyclovir	Valacyclovir Hcl	20	suppressed
Fentanyl	Fentanyl	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Cefdinir	Cefdinir	17	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Insulin Aspart Flexpen	Insulin Aspart	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Tiadylt Er	Diltiazem Hcl	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Diazepam	Diazepam	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Methimazole	Methimazole	11	suppressed
Risperidone	Risperidone	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error